DD-B4

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameDD-B4
Drug Alias NameDD-B4
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsNeuralgiaDementia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDiverdrugs
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDiverdrugs
Active IndicationsN/A
Inactive IndicationsNeuralgiaDementia

Other Information

ATC CodeN/A
Related LinksN/A